Aarti Drugs

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE767A01016
NSEID: AARTIDRUGS
BSEID: 524348

INR

328.45

3.45 (1.06%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 64.71 k

{
  "main_header": {
    "sid": 657348,
    "name": "Aarti Drugs",
    "stock_name": "Aarti Drugs",
    "full_name": "Aarti Drugs Ltd",
    "name_url": "stocks-analysis/aarti-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "328.45",
    "chg": 3.45,
    "chgp": "1.06%",
    "dir": 1,
    "prev_price": "325.00",
    "mcapval": "3,019.61 Cr",
    "mcap": "Small Cap",
    "scripcode": 524348,
    "symbol": "AARTIDRUGS",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE767A01016",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:17 AM",
    "bse_nse_vol": "64.71 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-drugs-657348-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Drugs Faces Significant Volatility Amid Declining Sales and Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-amid-ongoing-decline-and-poor-financial-performance-1406197",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AartiDrugs_priceRelatedfactors_682065.png",
        "date": "2025-03-17 15:39:47",
        "description": "Aarti Drugs has faced notable volatility, reaching a new 52-week low amid a five-day losing streak. The company reported a decline in net sales and operating profit growth, contrasting with the broader market's performance. Despite challenges, institutional investors have increased their stake, indicating interest in its fundamentals."
      },
      {
        "title": "Aarti Drugs Faces Continued Market Challenges Amid Significant Stock Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-amid-sustained-decline-and-sector-underperformance-1171218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AartiDrugs_priceRelatedfactors_561489.png",
        "date": "2025-03-03 09:36:42",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, has hit a new 52-week low, continuing a downward trend with a cumulative drop of 10.75% over six days. The stock is trading below all key moving averages and has declined 32.09% over the past year, underperforming the broader market."
      },
      {
        "title": "Aarti Drugs Faces Continued Decline Amidst Competitive Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-amid-continued-decline-in-stock-performance-1140696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AartiDrugs_priceRelatedfactors_548684.png",
        "date": "2025-02-28 10:05:55",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, is nearing a 52-week low, having declined for five consecutive days. The stock is trading below all key moving averages and has dropped 27.22% over the past year, contrasting with the Sensex's modest gain, indicating ongoing challenges in the market."
      },
      {
        "title": "Aarti Drugs Hits New Low Amid Ongoing Underperformance in Pharmaceutical Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-amid-consecutive-declines-and-underperformance-1129332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AartiDrugs_priceRelatedfactors_527896.png",
        "date": "2025-02-27 10:05:40",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, has reached a new 52-week low, reflecting a significant decline over the past four days. The stock has underperformed compared to its sector and the broader market, with a notable one-year return of -29.04%, indicating ongoing challenges for the company."
      },
      {
        "title": "Aarti Drugs Faces Volatility Amid Recent Stock Performance Challenges in February 2025",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-stock-gains-7-53-despite-ongoing-downward-trend-and-52-week-low-in-february25-1013333",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AartiDrugs_priceRelatedfactors_450238.png",
        "date": "2025-02-14 15:20:17",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, saw notable trading activity on February 14, 2025, despite facing a challenging period with a recent decline. The stock reached a new 52-week low, trading below key moving averages, and has underperformed compared to the broader market and its sector."
      },
      {
        "title": "Aarti Drugs Faces Significant Volatility Amid Sustained Stock Weakness in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-of-rs-375-75-amid-ongoing-decline-in-february-2025-1009170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AartiDrugs_priceRelatedfactors_441551.png",
        "date": "2025-02-14 10:05:32",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, has hit a new 52-week low amid significant volatility, marking a six-day decline of 11.17%. The stock has underperformed its sector and is down nearly 30% over the past year, trading below key moving averages, signaling ongoing challenges."
      },
      {
        "title": "Aarti Drugs Faces Significant Declines Amid Broader Market Volatility and Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-amid-26-37-annual-decline-and-high-volatility-987497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AartiDrugs_priceRelatedfactors_413401.png",
        "date": "2025-02-12 09:36:57",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, is facing significant challenges as its stock trades near a 52-week low, having declined 7.92% over the past four days. The stock has underperformed its sector and experienced notable volatility, reflecting ongoing struggles in the current market environment."
      },
      {
        "title": "Aarti Drugs Reports Q3 FY24-25 Results Amid Significant Financial Score Revision",
        "link": "https://www.marketsmojo.com/news/result-analysis/aarti-drugs-reports-significant-decline-in-q3-fy-2024-25-financial-performance-402162",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/AartiDrugs_quaterlyResult_283405.png",
        "date": "2025-01-29 19:01:21",
        "description": "Aarti Drugs has announced its financial results for the quarter ending January 2025, revealing a significant shift in its performance metrics. The company's evaluation score has changed notably, indicating challenges that have affected its financial standing and suggesting a transformation in its overall financial landscape."
      },
      {
        "title": "Aarti Drugs Hits 52-Week Low Amid Sustained Bearish Trend in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-drugs-hits-52-week-low-at-rs-392-amid-ongoing-decline-348358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/AartiDrugs_priceRelatedfactors_260368.png",
        "date": "2025-01-28 10:06:00",
        "description": "Aarti Drugs, a small-cap pharmaceutical company, has reached a new 52-week low, continuing a six-day downward trend with an overall decline of 8.12%. The stock is trading below multiple moving averages and has faced a 22.10% drop over the past year, contrasting with the Sensex's gains."
      }
    ],
    "total": 39,
    "sid": "657348",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/aarti-drugs-657348"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2025",
      "details": "Certificate under Re. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI Listing Regulations",
      "datetime": "02-Apr-2025",
      "details": "Disclosure under Regulation 30 of SEBI Listing Regulations - Cautionary letter from Stock Exchange.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Mar-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Feb 25",
          "dt": "2025-02-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20",
          "dt": "2020-09-30",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aarti Drugs Faces Significant Volatility Amid Declining Sales and Market Performance

2025-03-17 15:39:47

Aarti Drugs has faced notable volatility, reaching a new 52-week low amid a five-day losing streak. The company reported a decline in net sales and operating profit growth, contrasting with the broader market's performance. Despite challenges, institutional investors have increased their stake, indicating interest in its fundamentals.

Aarti Drugs Faces Continued Market Challenges Amid Significant Stock Volatility

2025-03-03 09:36:42

Aarti Drugs, a small-cap pharmaceutical company, has hit a new 52-week low, continuing a downward trend with a cumulative drop of 10.75% over six days. The stock is trading below all key moving averages and has declined 32.09% over the past year, underperforming the broader market.

Aarti Drugs Faces Continued Decline Amidst Competitive Market Challenges

2025-02-28 10:05:55

Aarti Drugs, a small-cap pharmaceutical company, is nearing a 52-week low, having declined for five consecutive days. The stock is trading below all key moving averages and has dropped 27.22% over the past year, contrasting with the Sensex's modest gain, indicating ongoing challenges in the market.

Aarti Drugs Hits New Low Amid Ongoing Underperformance in Pharmaceutical Sector

2025-02-27 10:05:40

Aarti Drugs, a small-cap pharmaceutical company, has reached a new 52-week low, reflecting a significant decline over the past four days. The stock has underperformed compared to its sector and the broader market, with a notable one-year return of -29.04%, indicating ongoing challenges for the company.

Aarti Drugs Faces Volatility Amid Recent Stock Performance Challenges in February 2025

2025-02-14 15:20:17

Aarti Drugs, a small-cap pharmaceutical company, saw notable trading activity on February 14, 2025, despite facing a challenging period with a recent decline. The stock reached a new 52-week low, trading below key moving averages, and has underperformed compared to the broader market and its sector.

Aarti Drugs Faces Significant Volatility Amid Sustained Stock Weakness in October 2023

2025-02-14 10:05:32

Aarti Drugs, a small-cap pharmaceutical company, has hit a new 52-week low amid significant volatility, marking a six-day decline of 11.17%. The stock has underperformed its sector and is down nearly 30% over the past year, trading below key moving averages, signaling ongoing challenges.

Aarti Drugs Faces Significant Declines Amid Broader Market Volatility and Sector Underperformance

2025-02-12 09:36:57

Aarti Drugs, a small-cap pharmaceutical company, is facing significant challenges as its stock trades near a 52-week low, having declined 7.92% over the past four days. The stock has underperformed its sector and experienced notable volatility, reflecting ongoing struggles in the current market environment.

Aarti Drugs Reports Q3 FY24-25 Results Amid Significant Financial Score Revision

2025-01-29 19:01:21

Aarti Drugs has announced its financial results for the quarter ending January 2025, revealing a significant shift in its performance metrics. The company's evaluation score has changed notably, indicating challenges that have affected its financial standing and suggesting a transformation in its overall financial landscape.

Aarti Drugs Hits 52-Week Low Amid Sustained Bearish Trend in Pharmaceuticals Sector

2025-01-28 10:06:00

Aarti Drugs, a small-cap pharmaceutical company, has reached a new 52-week low, continuing a six-day downward trend with an overall decline of 8.12%. The stock is trading below multiple moving averages and has faced a 22.10% drop over the past year, contrasting with the Sensex's gains.